HOPE in Action Prospective Multicenter, Clinical Trial of Deceased HIVD+ Kidney Transplants for HIV+ Recipients

What is the purpose of this trial?

This study will evaluate if receiving a kidney transplant from an HIV-infected deceased kidney donor is safe with regards to survival and major transplant-related and HIV-related complications compared to receiving a kidney from an HIV-uninfected deceased kidney donor (HIVD-). Those participants who have accepted an HIVD- organ will be randomized to be followed in the full study or followed in the nested observational group.

Participation Guidelines

Ages: 18 years and older

Gender: Both

National Institute of Allergy and Infectious Diseases

Start Date: 05/02/2018

End Date: 08/01/2021

Last Updated: 05/02/2019

Study HIC#: 2000022391

Get Involved

For more information about this study, contact:
Ricarda Tomlin
+1 203-785-2073

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 1-877-978-8348.

Trial Image


Maricar Malinis

Principal Investigator